Dyne Therapeutics, Inc. DYN Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s total operating expenses?
- Dyne Therapeutics, Inc. (DYN) reported total operating expenses of $125.28M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Dyne Therapeutics, Inc.'s total operating expenses increased by 2.4% year-over-year, from $122.37M to $125.28M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s total operating expenses has grown at a 32.9% compound annual growth rate (CAGR), from $150.03M to $468.18M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.